PERTH, Australia, Sept. 3, 2008-NeuroDiscovery Ltd (ASX: NDL), a specialty neuroscience services provider and drug development company, announces that its 100% subsidiary, NeuroSolutions Ltd, has entered into a research agreement with a major international pharmaceutical firm. The contract is worth £80,000 (approximately A$170,000) and is expected to take around 8 months to complete. The name of the client cannot be disclosed at this time.
